Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD L 506 for Intraoperative Visualisation of Breast Cancer
NCT01110954Phase 2Terminated
- Sponsor
- photonamic GmbH & Co. KG
- Start
- May 2010
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in breast cancer, sponsored by photonamic GmbH & Co. KG. Started May 2010; status: terminated.
02
Drugs
5-aminolevulinic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01110954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01110954.